Why the AstraZeneca-Oxford Covid-19 vaccine is different
If someone told you in March, when the World Health Organization finally called the Covid-19 outbreak a pandemic, that we’d have three strong coronavirus vaccine candidates by mid-November, you might have called that person delusional. Yet with Monday’s news from AstraZeneca and University of Oxford that early results from their phase 3 trial demonstrate their…